Search research articles
Contact Us
Filters
Showing results (171-180 of 175) with videos related to
Page
of 18
Sort By:
You have reached the last page of results.
This site can display upto 175 results.
Blood
|
May 30, 1998
p53 expression in B-cell chronic lymphocytic leukemia: a marker of disease progression and poor prognosis
I Cordone, S Masi, F R Mauro, et al.
Bone Marrow Transplantation
|
April 9, 2014
Use of G-CSF to hasten neutrophil recovery after auto-SCT for AML is not associated with increased relapse incidence: a report from the Acute Leukemia Working Party of the EBMT
T Czerw, M Labopin, N-C Gorin, et al.
Leukemia
|
January 18, 2008
NPM1-mutated acute myeloid leukaemia occurring in JAK2-V617F+ primary myelofibrosis: de-novo origin?
L Pasqualucci, S Li, G Meloni, et al.
Leukemia
|
January 12, 2017
Olaptesed pegol, an anti-CXCL12/SDF-1 Spiegelmer, alone and with bortezomib-dexamethasone in relapsed/refractory multiple myeloma: a Phase IIa Study
H Ludwig, K Weisel, M T Petrucci, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 5, 2003
Expression profiles of acute lymphoblastic and myeloblastic leukemias with ALL-1 rearrangements
T Rozovskaia, O Ravid-Amir, S Tillib, et al.
Page
of 18
Search research articles
Search
Showing results (171-180 of 175) with videos related to
Sort By:
Page
of 18
You have reached the last page of results.
This site can display upto 175 results.
Blood
|
May 30, 1998
p53 expression in B-cell chronic lymphocytic leukemia: a marker of disease progression and poor prognosis
I Cordone, S Masi, F R Mauro, et al.
Bone Marrow Transplantation
|
April 9, 2014
Use of G-CSF to hasten neutrophil recovery after auto-SCT for AML is not associated with increased relapse incidence: a report from the Acute Leukemia Working Party of the EBMT
T Czerw, M Labopin, N-C Gorin, et al.
Leukemia
|
January 18, 2008
NPM1-mutated acute myeloid leukaemia occurring in JAK2-V617F+ primary myelofibrosis: de-novo origin?
L Pasqualucci, S Li, G Meloni, et al.
Leukemia
|
January 12, 2017
Olaptesed pegol, an anti-CXCL12/SDF-1 Spiegelmer, alone and with bortezomib-dexamethasone in relapsed/refractory multiple myeloma: a Phase IIa Study
H Ludwig, K Weisel, M T Petrucci, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 5, 2003
Expression profiles of acute lymphoblastic and myeloblastic leukemias with ALL-1 rearrangements
T Rozovskaia, O Ravid-Amir, S Tillib, et al.
Page
of 18